VGAIT for Chemotherapy-induced Peripheral Neuropathy
Part of paid clinical trials in Charlestown, Massachusetts.
- Sponsor
- Massachusetts General Hospital
- Study ID
- NCT07177820
- Status
- Recruiting
Conditions
- Chemotherapy-induced Peripheral Neuropathy
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Video-Guided Acupuncture Imagery Treatment (VGAIT) — OTHERParticipants watch a video of acupuncture being applied to the body while simultaneously imagining that it is being administered to them
Study Details
Perform a feasibility study on imagined acupuncture treatment of Chemotherapy-induced peripheral neuropathy (CIPN)
Key Dates
- Start date
- Jan 6, 2026
- Status verified
- Feb 2026
- Primary completion
- Dec 1, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: VGAIT
Primary Outcome Measure
Feasibility related outcomes [ Time Frame: 8 week ]
Central Contacts
- Sierra Hodges6177265004
- Jian Kong16179620978
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Massachusetts General Hospital | Charlestown | Massachusetts | 02129 |
Find similar trials in Charlestown, MA
By research site
Related Studies
- Cryocompression for CIPNRecruiting · Dana-Farber Cancer Institute · Boston, Massachusetts
- Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral NeuropathyPHASE2 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas
- International CIPN Assessment and Validation StudyRecruiting · University of Milano Bicocca · Birmingham, Alabama
- Remote Monitoring and Management of Chemotherapy Induced Peripheral NeuropathyRecruiting · University of Vermont · Salt Lake City, Utah